对急性心肌梗死患者而言,尽早接受介入、溶栓等早期再灌注治疗,对恢复心肌血流畅通至关重要,可显著降低死亡率,改善预后,提高生活质量。然而,目前我国急性心梗患者能获得早期再灌注治疗的人数比例极低。在10月11-14日举行的第23届长城国际心脏病学会议暨亚太心脏大会上,与会专家呼吁,应加快急性心梗早期再灌注治疗的推广与规范,完善救治服务体系,使患者尽早获得最佳治疗。 For patients with acute myocardial infarction, early intervention, thrombolysis and other early reperfusion therapy is essential for the restoration of myocardial blood flow, can significantly reduce mortality, improve prognosis and improve quality of life. However, the current rate of early reperfusion in our patients with acute MI is extremely low. At the 23rd Great Wall International Cardiology Conference and the Asia-Pacific Heart Conference held on October 11-14, participating experts urged that the promotion and standardization of early reperfusion treatment of acute myocardial infarction should be expedited and the treatment service system should be perfected so as to enable patients as soon as possible Get the best treatment.